TYO:4594 Revenue

BrightPath Biotherapeutics had revenue of 12.00M JPY in the quarter ending December 31, 2018, a decrease of -81.25%. This brings the company's revenue in the last twelve months to 262.00M, down -23.84% year-over-year. In the fiscal year ending March 31, 2018, BrightPath Biotherapeutics had annual revenue of 354.00M, down -33.08%.

Revenue (ttm)

262.00M

Revenue Growth

-23.84%

P/S Ratio

13.47

Revenue / Employee

6.24M

Employees

Market Cap

3.53B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2018	354.00M	-175.00M	-33.08%
Mar 31, 2017	529.00M	-	-

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition